BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19114299)

  • 1. The levels of telomere-binding proteins in human tumours and therapeutic implications.
    Cookson JC; Laughton CA
    Eur J Cancer; 2009 Mar; 45(4):536-50. PubMed ID: 19114299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms.
    De Boeck G; Forsyth RG; Praet M; Hogendoorn PC
    J Pathol; 2009 Feb; 217(3):327-44. PubMed ID: 19142887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere neurobiology.
    Mattson MP; Zhang P; Cheng A
    Methods Mol Biol; 2008; 438():185-96. PubMed ID: 18369758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeres, telomerase and cellular immortalization.
    Jones CJ
    Symp Soc Exp Biol; 2000; 52():135-48. PubMed ID: 12090003
    [No Abstract]   [Full Text] [Related]  

  • 10. Telomeres: taking the measure.
    Lundblad V
    Nature; 2003 Jun; 423(6943):926-7. PubMed ID: 12827179
    [No Abstract]   [Full Text] [Related]  

  • 11. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.
    Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC
    Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
    Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H
    Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere maintenance in clinical medicine.
    Ulaner GA
    Am J Med; 2004 Aug; 117(4):262-9. PubMed ID: 15308436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone.
    Gebre-Medhin S; Broberg K; Jonson T; Gorunova L; von Steyern FV; Brosjö O; Jin Y; Gisselsson D; Panagopoulos I; Mandahl N; Mertens F
    Cytogenet Genome Res; 2009; 124(2):121-7. PubMed ID: 19420923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres as targets for anticancer therapies.
    Folini M; Venturini L; Cimino-Reale G; Zaffaroni N
    Expert Opin Ther Targets; 2011 May; 15(5):579-93. PubMed ID: 21288186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases.
    Raynaud CM; Mercier O; Commo F; Dartevelle P; Gomez-Roca C; de Montpreville V; Sabatier L; Soria JC
    Lung Cancer; 2009 Aug; 65(2):144-9. PubMed ID: 19091442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten1p promotes the telomeric DNA-binding activity of Cdc13p: implication for its function in telomere length regulation.
    Qian W; Wang J; Jin NN; Fu XH; Lin YC; Lin JJ; Zhou JQ
    Cell Res; 2009 Jul; 19(7):849-63. PubMed ID: 19532124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.